List Title | APhA DrugInfoLine

Infectious Diseases

SORT BY: Most Recent Most Viewed

August 22, 2017

Pneumococcal coverage rates low in Medicare beneficiaries

READ

PREVIEW
An assessment of Medicare claims in adults (i.e., ≥65 y) for the 13-valent pneumococcal conjugate vaccine (PCV13) and the 23-valent pneumococcal polysaccharide vaccine (PPSV23) over a 7-year...
August 21, 2017

CDC releases updated guideline for prevention of surgical site infections

READ

PREVIEW
CDC’s updated guideline for prevention of surgical site infections includes recommendations on antiseptic prophylaxis, antibiotic prophylaxis, glycemic control, oxygenation, and other topics.
August 1, 2017

Antibiotic-associated adverse effects common in hospitalized patients

READ

PREVIEW
Results of a retrospective cohort analysis at a large academic medical center showed that gastrointestinal (GI), renal, and hematologic abnormalities were common adverse events (AEs) in...
June 20, 2017

ACCP releases resource on managing HIV-infected patients admitted to the hospital

READ

PREVIEW
The American College of Clinical Pharmacy (ACCP) published a resource in Pharmacotherapy that focused on areas to consider when managing patients with HIV infection who are admitted to...
May 23, 2017

Cefazolin for definitive treatment of MSSA infections complicated by bacteremia

READ

PREVIEW
Use of cefazolin for the treatment of methicillin-susceptible Staphylococcus aureus (MSSA) infections resulted in a greater reduction in 30- and 90-day mortality compared with treatment...

Pages

Medication Monitor

RSS Follow Medication Monitor on Twitter Follow APhA Druginfoline on Twitter

2215 Constitution Avenue NW, Washington, DC 20037 Telephone 202-628-4410 Fax 202-783-2351

© 2013 American Pharmacists Association All Rights Reserved.

About the American
Pharmacists Association

The American Pharmacists Association (APhA) is the organization whose members are recognized in society as essential in all patient care settings for optimal medication use that improves health, wellness and quality of life. Through information, education and advocacy, APhA empowers its members to improve medication use and advance patient care.

About APhA DrugInfoLine

APhA DrugInfoLine (ISSN 2162-3015) is a weekly publication of, and is owned and copyrighted by the American Pharmacists Association, the national professional society of pharmacists. Materials in APhA DrugInfoLine do not neccessarily represent the policy, recommendations, or endorsement of APhA. The publisher, authors, editors, reviewers, and contributors have taken care to ensure that the information contained in APhA DrugInfoLine is accurate and current; however, they shall have no ability to any person or entity with regard to claims, losses, or damage caused or alleged to be caused, directly or indirectly by use of any information contained in the publication. All decisions about drug therapy must be based on independent judgement of the clinician.